05 de junho de 2019
Share
The event, which took place on June 5th, 2019, in Philadelphia, United States, discussed the current scenario and future opportunities for the Brazilian pharmaceutical market related to rare diseases. They also addressed questions about the public health system in Brazil, the paths to the approval of a new medication, among others.